AR and prostate carcinoma: Given that prostate cancer cell growth is coupled to AR signaling, which in CRPC is linked to de novo steroidogenesis that uses cholesterol as a precursor [7], we hypothesized that LDL-inducible changes in cell proliferation of AR-positive C4-2B cells could be associated with activation of AR signaling.